Lung Diseases
Respiratory·MeSH: Lung Diseases
8 drugs in development·8 companies·10 clinical trials
Drug Pipeline by Phase
Approved(6)
Phase 3(1)
| Drug | Company |
|---|---|
| Nerandomilast | Valneva SE (VALN) |
Preclinical(1)
| Drug | Company |
|---|---|
| eq504 | Equillium, Inc. (EQ) |
Compare drugs
Frequently asked questions
How many drugs are in development for Lung Diseases?
BioSniper tracks 8 drugs in development for Lung Diseases across 8 companies.
How many clinical trials target Lung Diseases?
There are 10 clinical trials targeting Lung Diseases tracked by BioSniper.
Deep-dive into Lung Diseases
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis